Today, a Director at Conmed Corp (CNMD), Dirk Kuyper, sold shares of CNMD for $744.4K.
Following Dirk Kuyper’s last CNMD Sell transaction on June 14, 2017, the stock climbed by 32.8%. In addition to Dirk Kuyper, 3 other CNMD executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Conmed Corp’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $217 million and quarterly net profit of $1.02 million. In comparison, last year the company earned revenue of $202 million and had a net profit of $10.66 million. CNMD’s market cap is $2.35B and the company has a P/E ratio of 77.21. Currently, Conmed Corp has an average volume of 35.02K.
Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $96.00, reflecting a 15.2% upside.
The insider sentiment on Conmed Corp has been negative according to 51 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.
Dirk Kuyper’s trades have generated a -6.1% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific.
